Live Breaking News & Updates on அமைப்பு அட்ரோஃபீ

Stay updated with breaking news from அமைப்பு அட்ரோஃபீ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Appendix 4C - Q4 FY21 Quarterly Cash Flow Report


Publication in
Presents to MST Access Australian Micro & Small Caps Conference
Cash balance at 30 June 2021 of A$28M
MELBOURNE, Australia, July 30, 2021 /PRNewswire/ Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) ( Alterity or the Company ), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, releases its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter ending 30 June 2021 (Q4 FY21).
The Company’s cash position at 30 June 2021 of $28M was bolstered by the receipt of $17M in net proceeds from the use of the company’s previously approved At the Market facility with shares issued in accordance with ASX Listing Rules 7.1 and 7.1A. ....

United States , San Francisco , David Stamler , Movement Disorders , Company Phase , Vanderbilt University Medical Center , Movement Disorder Society , Drug Administration , European Union , European Medicines Agency , International Parkinson , Alterity Therapeutics Limited , Alterity Therapeutics , Publication In Movement Disorders , Australian Micro , Small Caps Conference , Quarterly Cash Flow Report , Multiple System Atrophy , Natural History , Vanderbilt University Medical , Chief Executive Officer , Small Caps , System Atrophy , Lewy Bodies , ஒன்றுபட்டது மாநிலங்களில் , சான் பிரான்சிஸ்கோ ,